If the lived experiences of patients are not considered across health solutions or drug development, we risk making assumptions about patient perspectives, preferences, and needs. This can result in products, services, or solutions that aren’t right for those who use them. Gathering patient insights too late, or not at all, not only leads to a lack of an authentic approach but also generates inefficiencies, excess costs, and delays across the drug development lifecycle.
Expertise in patient community collaboration and generating patient insights
From small biotech to big pharma, we offer bespoke strategic consultancy to support you across the development and implementation of effective patient engagement strategies, companywide or across therapy areas, functions, or teams.
We support you in creating effective patient education and support resources. Health literacy and inclusivity form the foundation of everything we do.
We are committed to improving diversity, equity, and inclusion (DE&I) within healthcare, and we recognize that this is a rapidly evolving space with the opportunity to positively impact outcomes for all. We work directly with you and the patient communities you serve to understand critical DE&I gaps and develop solutions to help close them.
We are thought leaders in the industry, driving the conversation and challenging our peers.
Read more about what our experts have to say.
We discuss how to ensure that patient-reported outcomes (PROs) are relevant and accurately capture the patient experience, through collaboration...
By understanding barriers to patient activation through a behavioural science lens, we discuss a behaviour change framework to identify...
Learn more about MEDiSTRAVA’s strategic solutions and how we can help your business tackle the unique and evolving needs of leadership and Medical teams.
